Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

FluoGuide

33.90 SEK+0.30 %7.10, 17.25
Less than 1K followers

FLUO

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor views
Compare
+0.30 %
-6.09 %
-13.52 %
-10.08 %
-1.17 %
-22.95 %
-62.33 %
-64.50 %
+278.13 %

FluoGuide is a Danish company operating in the medical technology sector. The company's business focus is on research and development of treatments for various forms of cancer, with the greatest focus on the development of products that guide surgical procedures. The products bind to cancer cells, which then light up and are intended to be used to precisely remove harmful tumors in the patient's tissue.

Read more
Market cap
554.24M SEK
Turnover
247.46K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Research
Webcasts
Press releases
ShowingAll content types

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
26.11
2026

Interim report Q3'26

24.2
2027

Annual report '26

16.3
2027

General meeting '27

Press release07.10.2026, 10.33

Redeye: FluoGuide: First patient enrolled in US Phase II registration-supporting trial

FluoGuide
Press release07.10.2026, 10.03

BioStock: FluoGuide enrols first patient in US brain cancer trial

FluoGuide
Press release05.10.2026, 16.26

Redeye: FluoGuide: Collaboration with Leica Microsystems expands microscope coverage

FluoGuide

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release05.10.2026, 14.42

DNB Carnegie Access: FluoGuide: First US HGG patient enrolled – important clinical milestone

FluoGuide
Press release05.10.2026, 13.41

FluoGuide enrolls first patient in U.S. Phase 2 trial of FG001 in high-grade glioma

FluoGuide
Press release05.10.2026, 08.34

DNB Carnegie Access: FluoGuide: Adds Leica as fifth medtech partner

FluoGuide
Regulatory press release02.10.2026, 18.25

FluoGuide enters collaboration with Leica Microsystems, a world leading medical technology company

FluoGuide
Press release24.09.2026, 10.21

BioStock: Video from FluoGuide's presentation at BioStock Investing in Life Science 2026

FluoGuide
HCA Morgenbørs 24/09 – Interview med Kim Mikkelsen fra Strategic Investments og udsigt til negativ åbning
Video24.09.2026, 10.00 by
Rasmus Køjborg, Jacob Frehr

HCA Morgenbørs 24/09 – Interview med Kim Mikkelsen fra Strategic Investments og udsigt til negativ åbning

Udsigt til en negativ dag i Europa efter at den 5-årige statsrente i USA bryder op over 5%. Fokus på TORM efter at Hafnia øger sin andel. Gæst i studiet her til morgen er investeringschef Kim Mikkelsen fra Strategic Investments.

GreenMobilityDSVWindowMaster InternationalBar DjusFluoGuideTormHafnia
Press release10.09.2026, 09.00

BioStock: Fluoguide to Present at Investing in Life Science on September 22

FluoGuide
Press release25.08.2026, 17.35

Redeye: FluoGuide (Q2 Review): Building on its repertoire of clinical evidence

FluoGuide
Press release25.08.2026, 16.47

DNB Carnegie Access: FluoGuide: Pipeline progression on track – Q2 review

FluoGuide
Regulatory press release25.08.2026, 07.10

FluoGuide A/S publishes interim report for Q2 2026

FluoGuide
Press release17.08.2026, 06.12

DNB Carnegie Access: FluoGuide: Illuminating new technology in cancer surger

FluoGuide
Press release12.08.2026, 10.48

Invitation to FluoGuide A/S live webcast on 25 August 2026

FluoGuide
Press release01.07.2026, 08.36

Update on 2026 Outlook and Company progress

FluoGuide
Press release30.06.2026, 10.00

Redeye: FluoGuide: First part of Phase 2 HNC trial clears dose-finding phase

FluoGuide
Press release29.06.2026, 10.32

FluoGuide announces positive results from Phase 2 oral head and neck cancer trial

FluoGuide
Press release28.05.2026, 18.35

Redeye: FluoGuide (Q1 Review): Catalyst-Heavy Remainder of 2026

FluoGuide
Regulatory press release27.05.2026, 07.09

FluoGuide A/S publishes interim report for Q1 2026

FluoGuide